These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2837017)

  • 41. Establishment and Application of Flavivirus Replicons.
    Kümmerer BM
    Adv Exp Med Biol; 2018; 1062():165-173. PubMed ID: 29845532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of dengue virus NS4A and NS4B protein interaction.
    Zou J; Xie X; Wang QY; Dong H; Lee MY; Kang C; Yuan Z; Shi PY
    J Virol; 2015 Apr; 89(7):3455-70. PubMed ID: 25568208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kunjin RNA replication and applications of Kunjin replicons.
    Westaway EG; Mackenzie JM; Khromykh AA
    Adv Virus Res; 2003; 59():99-140. PubMed ID: 14696328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Membrane association and secretion of the Japanese encephalitis virus NS1 protein from cells expressing NS1 cDNA.
    Fan WF; Mason PW
    Virology; 1990 Aug; 177(2):470-6. PubMed ID: 2142554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication.
    Liu WJ; Chen HB; Khromykh AA
    J Virol; 2003 Jul; 77(14):7804-13. PubMed ID: 12829820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular cloning and characterization of the genes encoding the proteins of Zika virus.
    Hou W; Cruz-Cosme R; Armstrong N; Obwolo LA; Wen F; Hu W; Luo MH; Tang Q
    Gene; 2017 Sep; 628():117-128. PubMed ID: 28720531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Complement System in Flavivirus Infections.
    Conde JN; Silva EM; Barbosa AS; Mohana-Borges R
    Front Microbiol; 2017; 8():213. PubMed ID: 28261172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of novel viral polyproteins detected in cells infected by the flavivirus Kunjin and radiolabelled in the presence of the leucine analogue hydroxyleucine.
    Crawford GR; Wright PJ
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():365-76. PubMed ID: 3029280
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription.
    Liu WJ; Chen HB; Wang XJ; Huang H; Khromykh AA
    J Virol; 2004 Nov; 78(22):12225-35. PubMed ID: 15507609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis of dengue virus RNA in vitro: initiation and the involvement of proteins NS3 and NS5.
    Bartholomeusz AI; Wright PJ
    Arch Virol; 1993; 128(1-2):111-21. PubMed ID: 8418788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nucleotide sequence of the NS5 gene of Banzi virus: comparison with other flaviviruses.
    Fulop LD; Barrett AD; Titball RW
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2317-21. PubMed ID: 7561771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles.
    Kümmerer BM; Rice CM
    J Virol; 2002 May; 76(10):4773-84. PubMed ID: 11967294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b.
    Putnak JR; Schlesinger JJ
    J Gen Virol; 1990 Aug; 71 ( Pt 8)():1697-702. PubMed ID: 2144016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE).
    Pugachev KV; Schwaiger J; Brown N; Zhang ZX; Catalan J; Mitchell FS; Ocran SW; Rumyantsev AA; Khromykh AA; Monath TP; Guirakhoo F
    Vaccine; 2007 Sep; 25(37-38):6661-71. PubMed ID: 17693000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
    Lai H; Teramoto T; Padmanabhan R
    Methods Mol Biol; 2014; 1138():345-60. PubMed ID: 24696347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Processing of nonstructural proteins NS4A and NS4B of dengue 2 virus in vitro and in vivo.
    Preugschat F; Strauss JH
    Virology; 1991 Dec; 185(2):689-97. PubMed ID: 1683727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overview of flavivirus molecular biology and future vaccine development via recombinant DNA.
    Rice CM
    Southeast Asian J Trop Med Public Health; 1990 Dec; 21(4):670-7. PubMed ID: 1965931
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins.
    Weiner AJ; Brauer MJ; Rosenblatt J; Richman KH; Tung J; Crawford K; Bonino F; Saracco G; Choo QL; Houghton M
    Virology; 1991 Feb; 180(2):842-8. PubMed ID: 1846505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful competition in translation by the flavivirus Kunjin with poliovirus during co-infections in Vero cells.
    Schrader AP; Westaway EG
    Arch Virol; 1990; 114(1-2):75-89. PubMed ID: 2171465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of flavivirus RNA in infected cells using photobiotin-labelled hybridization probes.
    Khan AM; Wright PJ
    J Virol Methods; 1987 Feb; 15(2):121-30. PubMed ID: 3031110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.